Instinct Bio Technical Company Holdings Inc

Instinct Bio Technical Company Holdings Inc(BIOT)股票分析

$0.222

-0.006 (-2.76%)收盘时

Loading chart…
最高
0.260
开盘
0.236
成交量加权均价
0.23
成交量
582.77K
市值
—
最低
0.212
成交额
134.76K
企业价值/息税折旧摊销前利润(TTM)
0.00

Instinct Bio Technical Company Holdings Inc. is a vertically integrated biotechnology holding company that works in stem cell and regenerative medicine-related fields, wellness and beauty. It operates through subsidiaries. The core activities include research and development in regenerative stem cell cosmetics that focus on regenerative stem cell technology for advanced skincare and personal care formulations, raw materials and supply chain management including procurement, distribution and logistics of raw materials essential for stem cell-conditioned media, original equipment manufacturer and original design manufacturer (OEM/ODM) cosmetic products provision, brand franchising, branding and creative design solutions provision, influencer and celebrity brand collaborations and e-commerce platforms operation. Its product categories include skincare, body and hair care, inner care and supplements, and professional line. Its brands include MANOROL, HAKUA, VIVEA, GENREVER and others.

AI 分析 of Instinct Bio Technical Company Holdings Inc (BIOT)

卖出

Given the current price of $0.23 and an RSI of 9.446, which indicates extreme oversold conditions, this asset is not a good buy right now due to significant downward momentum and lack of positive catalysts.

估值指标

Instinct Bio Technical Company Holdings Inc(BIOT)当前预期市盈率为 0.00,5 年平均预期市盈率为 。

预期市盈率

5 年均值 P/E
当前P/E
0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA
当前EV/EBITDA
0.00

预期市销率

5 年均值 P/S
当前P/S
0.00

BIOT 常见问题 —— 由 Alphio AI 解答

Instinct Bio Technical Company Holdings Inc. is a vertically integrated biotechnology holding company that works in stem cell and regenerative medicine-related fields, wellness and beauty. It operates through subsidiaries. The core activities include research and development in regenerative stem cell cosmetics that focus on regenerative stem cell technology for advanced skincare and personal care formulations, raw materials and supply chain management including procurement, distribution and logistics of raw materials essential for stem cell-conditioned media, original equipment manufacturer and original design manufacturer (OEM/ODM) cosmetic products provision, brand franchising, branding and creative design solutions provision, influencer and celebrity brand collaborations and e-commerce platforms operation. Its product categories include skincare, body and hair care, inner care and supplements, and professional line. Its brands include MANOROL, HAKUA, VIVEA, GENREVER and others. It operates in the Consumer Non-Cyclicals sector.

Given the current price of $0.23 and an RSI of 9.446, which indicates extreme oversold conditions, this asset is not a good buy right now due to significant downward momentum and lack of positive catalysts.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易